Skip to main content

Peer Review reports

From: Oral high dose ascorbic acid treatment for one year in young CMT1A patients: a randomised, double-blind, placebo-controlled phase II trial

Original Submission
30 Oct 2009 Submitted Original manuscript
30 Oct 2009 Author responded Author comments - Camiel Verhamme
Resubmission - Version 2
30 Oct 2009 Submitted Manuscript version 2
1 Nov 2009 Author responded Author comments - Camiel Verhamme
Resubmission - Version 3
1 Nov 2009 Submitted Manuscript version 3
Publishing
12 Nov 2009 Editorially accepted
12 Nov 2009 Article published 10.1186/1741-7015-7-70

You can find further information about peer review here.

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us